Despite extensive research, effective treatments for AD remain limited, and current therapeutic approaches, such as acetylcholinesterase inhibitors and glutamate regulators, only provide symptomatic relief without inhibiting disease progression [3]. This evidence concerns the gene ACHE and Alzheimer disease.